Doxorubicin

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue SarcomaNCT01514188IBRXPhase 2Completed2014-04-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.